Eversept Partners, LP Vertex Pharmaceuticals Inc Call Options Transaction History

Eversept Partners, LP

  • $1.26 Billion
  • Q3 2024

Call Options

3 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q4 2021

Nov 08, 2023
SELL
$177.01 - $223.45 $14 Million - $17.7 Million
-79,200 Reduced 45.7%
94,100 $20.7 Million
Q2 2021

Nov 08, 2023
BUY
$187.49 - $221.1 $21.2 Million - $25.1 Million
113,300 Added 188.83%
173,300 $34.9 Million
Q1 2021

Nov 08, 2023
BUY
$207.02 - $241.31 $12.4 Million - $14.5 Million
60,000 New
60,000 $12.9 Million

Others Institutions Holding VRTX

# of Institutions
1,723
Shares Held
222M
Call Options Held
1.58M
Put Options Held
1.36M
View Full List

About VERTEX PHARMACEUTICALS INC

VRTX Quotes by TradingView
  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $116B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Eversept Partners, LP Portfolio

Follow Eversept Partners, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eversept Partners, LP, based on Form 13F filings with the SEC.

News

Stay updated on Eversept Partners, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email